Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Norrie Russell; Eric Fung; and More

Premium

Sialix this week appointed Norrie Russell president and CEO – a newly established full-time position at the company.

Previously Russell was president of Gene Logic, the US operating division of Ocimum Biosolutions. Before that he was president and chief operating officer of NovaRx and chief scientific officer at Invitrogen, now Life Technologies.


Biognosys announced this week that it has added Ignacio Martinez, Hellmut Kirchner, and Harry Welton to its board of directors.

Martinez is a principal at Syngenta Ventures, a participant in the CHF2.7 million ($3 million) funding round the company announced this week (see story this issue). Kirchner is co-founder of the venture fund TVM, also a participant in the funding round. Welton has served as chief financial officer of several biotech firms including Arpida.


Vermillion this week entered into a consulting agreement with Eric Fung under which Fung will continue to serve as the company's chief medical officer and member of its scientific advisory board but will be paid on an hourly basis.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more